Seeking Alpha

John Putnam » Profile

John M. Putnamhas been covering the Medical Device and Technology industry on Wall Street for more than 30 years. He previously served as Senior Medical Device Analyst at Dawson James and Stanford Financial Group. He also held similar positions at Smith Barney, Wellington Management, L.F. Rothschild, Alex Brown & Sons, Adams, Harkness & Hill, and Gruntal. He was also a principle and co-founder of Belmont Harbor Capital, a boutique investment research and merchant bank in Chicago.

As an analyst for the past three decades, Mr. Putnam has been responsible for the technology, fundamental, regulatory and reimbursement research of the medical device industry. He has extensive knowledge of many segments of the medical device and technology industry including cardiovascular, orthopedics, diagnostics, and urology and the healthcare information industry. He was one of the first analysts on Wall Street to identify angioplasty and Women’s Health as major investment opportunities. He has a strong financial background and actually enjoys reading and analyzing financial statements and performing due diligence. He also spent several years in Washington D.C., focusing on regulatory and reimbursement issues impacting the medical device industry.

In addition to strong writing and personal communications skill, Mr. Putnam also developed a proprietary research methodology that evaluates the competitive position of companies participating in a particular industry segment by analyzing their intellectual property as embodied in a company’s patent portfolio. This methodology can be used to perform strategic planning and business development. It identifies each company’s relative competitive position within a technology and can identify those companies that are either active or have become inactive in research and development in that specific technology. From a business development perspective it can also identify a patent portfolio that may no longer be relevant to its holder but that may be an opportunity for another company.

Mr. Putnam holds an MBA from The George Washington University and a BA from Baldwin-Wallace College. He is a Chartered Financial Analyst and a member of the Boston Security Analysts Society.

John Putnam's Company

NextWave Research, Inc. With over 30 years experience as a Wall Street institutional analyst, I’m very well known in the financial media and on Wall Street (if you Google “john putnam” “analyst” my work covers 20 pages of results). As you can imagine, my research coverage results in a significant increase in a company’s visibility and trading.
At NextWave Research, my most recent research articles have generated 78,363 impressions and over 4,125 reads, from more than 20 countries. And most importantly, it is freely accessible, worldwide, in 11 languages, to all investors on our well-regarded website at http://www.NextWaveResearch.com.
Today, close to 50% of all public companies have no research coverage at all, while at least 75% of all firms are under covered (defined as having less than 3 analysts covering these companies). As a result, these public companies suffer a discount in their stock price that can directly be attributed to their lack of research coverage. Unfortunately, given the economics of the small cap equity market, combined with the pressure most investment banks and brokerage firms are facing today, it is highly unlikely that small and micro cap companies will find it easier to get sell-side research coverage in the future.
Our website (http://nextwaveresearch.com) fully describes our unique approach to research and reasons your company should strongly consider becoming a client of NextWave Research. Please call me at your convenience to explore how together we can help you increase your investment visibility.
Visit http://nextwaveresearch.com »
Articles by John Putnam »
Snapshot
  • Analyst
  • Trading frequency: Daily
Interests:
  • Stocks - long
  • Stocks - short